<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about OCR</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Tue, 18 Jun 2013 20:40:11 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=OCR" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/omnicare-unit-partners-drug-buster-analyst-blog-cm249748">
      <guid isPermaLink="false">249748</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/avNPHHLRZCg/omnicare-unit-partners-drug-buster-analyst-blog-cm249748</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Omnicare Unit Partners Drug Buster - Analyst Blog</title>
      <description>Provider of drugs to long-term care facilities and nursing homes,  Omnicare Inc.  (  OCR  ) recently reported that Hospice Pharmacia, an offering of excelleRx Inc., an Omnicare Company, has&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/avNPHHLRZCg" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 30 May 2013 22:28:04 Z</pubDate>
      <a10:updated>2013-05-30T19:31:14Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CVD</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>OCR</nasdaq:tickers>
      <nasdaq:tickers>PMC</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/omnicare-unit-partners-drug-buster-analyst-blog-cm249748</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/omnicare-inc-ocr-exdividend-date-scheduled-for-may-30-2013-cm249277">
      <guid isPermaLink="false">249277</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sHWv2Uzj1KM/omnicare-inc-ocr-exdividend-date-scheduled-for-may-30-2013-cm249277</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Omnicare, Inc. (OCR) Ex-Dividend Date Scheduled for May 30, 2013</title>
      <description>Omnicare, Inc. (  OCR  ) will begin trading ex-dividend on May 30, 2013. A cash dividend payment of $0.14 per share is scheduled to be paid on June 14, 2013. Shareholders who purchased OCR stock&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/sHWv2Uzj1KM" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 29 May 2013 17:00:04 Z</pubDate>
      <a10:updated>2013-05-29T13:18:53Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>ESRX</nasdaq:tickers>
      <nasdaq:tickers>OCR</nasdaq:tickers>
      <nasdaq:tickers>TTFS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/omnicare-inc-ocr-exdividend-date-scheduled-for-may-30-2013-cm249277</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/abco-posts-solid-4q-and-fy2013-earnings-analyst-blog-cm245620">
      <guid isPermaLink="false">245620</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R0OZyLYyJxI/abco-posts-solid-4q-and-fy2013-earnings-analyst-blog-cm245620</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>ABCO Posts Solid 4Q and FY2013 Earnings - Analyst Blog</title>
      <description>The Advisory Board Company  (  ABCO  ) reported fourth quarter fiscal 2013 operating earnings of 33 cents per share surpassing the Zacks Consensus Estimate of 21 cents per share. Results also&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/R0OZyLYyJxI" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 13 May 2013 18:50:01 Z</pubDate>
      <a10:updated>2013-05-13T16:18:31Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABCO</nasdaq:tickers>
      <nasdaq:tickers>CRL</nasdaq:tickers>
      <nasdaq:tickers>CVD</nasdaq:tickers>
      <nasdaq:tickers>OCR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/abco-posts-solid-4q-and-fy2013-earnings-analyst-blog-cm245620</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/charles-river-misses-estimates-in-1q-analyst-blog-cm243199">
      <guid isPermaLink="false">243199</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BDrpNUXLhzc/charles-river-misses-estimates-in-1q-analyst-blog-cm243199</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Charles River Misses Estimates in 1Q - Analyst Blog</title>
      <description>Charles River Laboratories  (  CRL  ) reported first  quarter 2013 earnings (excluding special items) of 63 cents per  share, missing the Zacks Consensus Estimate of 71 cents. Earnings  were&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/BDrpNUXLhzc" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 02 May 2013 21:44:01 Z</pubDate>
      <a10:updated>2013-05-02T17:54:12Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CRL</nasdaq:tickers>
      <nasdaq:tickers>EMD</nasdaq:tickers>
      <nasdaq:tickers>MDAS</nasdaq:tickers>
      <nasdaq:tickers>OCR</nasdaq:tickers>
      <nasdaq:tickers>PCS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/charles-river-misses-estimates-in-1q-analyst-blog-cm243199</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/esrx-beats-1q-earnings-revenues-estimate-analyst-blog-cm242182">
      <guid isPermaLink="false">242182</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mqmFVTcQ-hQ/esrx-beats-1q-earnings-revenues-estimate-analyst-blog-cm242182</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>ESRX Beats 1Q Earnings &amp; Revenues Estimate - Analyst Blog</title>
      <description>Express Scripts Holding Company's  (  ESRX  ) first quarter 2013 adjusted earnings of 99 cents per share beat the Zacks Consensus Estimate by a penny and increased 35.6% from the year-ago&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/mqmFVTcQ-hQ" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 30 Apr 2013 20:51:53 Z</pubDate>
      <a10:updated>2013-04-30T17:58:00Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CTRX</nasdaq:tickers>
      <nasdaq:tickers>ESRX</nasdaq:tickers>
      <nasdaq:tickers>MDAS</nasdaq:tickers>
      <nasdaq:tickers>OCR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/esrx-beats-1q-earnings-revenues-estimate-analyst-blog-cm242182</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/ocr-beats-on-earnings-est-misses-rev-analyst-blog-cm240796">
      <guid isPermaLink="false">240796</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QulKPcYadPw/ocr-beats-on-earnings-est-misses-rev-analyst-blog-cm240796</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>OCR Beats on Earnings Est; Misses Rev - Analyst Blog</title>
      <description>Provider of drugs to long-term care facilities and nursing homes,  Omnicare Inc.  (  OCR  ) posted first quarter 2013 adjusted (excluding one-time expenses) earnings per share of 90 cents&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/QulKPcYadPw" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 25 Apr 2013 23:13:36 Z</pubDate>
      <a10:updated>2013-04-25T20:17:41Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>CYBX</nasdaq:tickers>
      <nasdaq:tickers>OCR</nasdaq:tickers>
      <nasdaq:tickers>PMC</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/ocr-beats-on-earnings-est-misses-rev-analyst-blog-cm240796</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/omnicare-bull-thinks-of-time-as-money-cm234158">
      <guid isPermaLink="false">234158</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vpLsFleDzys/omnicare-bull-thinks-of-time-as-money-cm234158</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Omnicare bull thinks of time as money</title>
      <description>Omnicare has been grinding higher, and one investor is using options to turn time into money.    Our tracking systems detected the purchase of 2,000 June 38 calls for $3 and the sale of an equal&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/vpLsFleDzys" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 02 Apr 2013 13:45:44 Z</pubDate>
      <a10:updated>2013-04-05T17:15:56Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>OCR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/omnicare-bull-thinks-of-time-as-money-cm234158</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/forex-audnzd-reaches-2month-high-after-rbnz-cm226902">
      <guid isPermaLink="false">226902</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gwz6_o7xn1s/forex-audnzd-reaches-2month-high-after-rbnz-cm226902</link>
      <category>Investing</category>
      <category>Forex and Currencies</category>
      <title>Forex: AUD/NZD reaches 2-month high after RBNZ</title>
      <description>The New Zealand dollar weakened broadly and fell to its lowest level in 2 months against its neighbor the Aussie, after the RBNZ decided to keep its monetary policy unchanged but said it expects&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Gwz6_o7xn1s" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 14 Mar 2013 00:27:00 Z</pubDate>
      <a10:updated>2013-03-13T22:12:29Z</a10:updated>
      <author>FXstreet.com</author>
      <nasdaq:tickers>OCR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/forex-audnzd-reaches-2month-high-after-rbnz-cm226902</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/rbnz-leaves-interest-rate-unchanged-at-25-cm226907">
      <guid isPermaLink="false">226907</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y-ZKxxJLDBY/rbnz-leaves-interest-rate-unchanged-at-25-cm226907</link>
      <category>Investing</category>
      <category>Forex and Currencies</category>
      <title>RBNZ leaves interest rate unchanged at 2.5%</title>
      <description>The Reserve Bank of New Zealand decided today to leave the Official Cash Rate (  OCR  ) unchanged at 2.5% as expected.    In a statement, Reserve Bank Governor Graeme Wheeler said that the&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/y-ZKxxJLDBY" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 14 Mar 2013 00:09:00 Z</pubDate>
      <a10:updated>2013-03-13T22:13:14Z</a10:updated>
      <author>FXstreet.com</author>
      <nasdaq:tickers>OCR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/rbnz-leaves-interest-rate-unchanged-at-25-cm226907</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/omnicare-inc-ocr-exdividend-date-scheduled-for-march-05-2013-cm222423">
      <guid isPermaLink="false">222423</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qeetRcR0yCs/omnicare-inc-ocr-exdividend-date-scheduled-for-march-05-2013-cm222423</link>
      <category>News Headlines</category>
      <category>Stocks</category>
      <title>Omnicare, Inc. (OCR) Ex-Dividend Date Scheduled for March 05, 2013</title>
      <description>Omnicare, Inc. (  OCR  ) will begin trading ex-dividend on March 05, 2013. A cash dividend payment of $0.14 per share is scheduled to be paid on March 22, 2013. Shareholders who purchased OCR&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/qeetRcR0yCs" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 01 Mar 2013 19:00:04 Z</pubDate>
      <a10:updated>2013-03-01T14:19:02Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>ESRX</nasdaq:tickers>
      <nasdaq:tickers>OCR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/omnicare-inc-ocr-exdividend-date-scheduled-for-march-05-2013-cm222423</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/company-news-for-february-20-2013-corporate-summary-cm219278">
      <guid isPermaLink="false">219278</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Spt7DybYkoQ/company-news-for-february-20-2013-corporate-summary-cm219278</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Company News for February 20, 2013 - Corporate Summary</title>
      <description>•    Omnicare, Inc. (NYSE:  OCR  ) reported fourth quarter earnings per share of $0.86, beating the Zacks Consensus Estimate of $0.85    •    Cedar Fair, L.P.&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Spt7DybYkoQ" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 20 Feb 2013 19:36:01 Z</pubDate>
      <a10:updated>2013-02-20T15:54:02Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>EE</nasdaq:tickers>
      <nasdaq:tickers>FUN</nasdaq:tickers>
      <nasdaq:tickers>OCR</nasdaq:tickers>
      <nasdaq:tickers>SEE</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/company-news-for-february-20-2013-corporate-summary-cm219278</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/omnicare-tops-est-higher-profit-analyst-blog-cm219231">
      <guid isPermaLink="false">219231</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wtZKdIomluA/omnicare-tops-est-higher-profit-analyst-blog-cm219231</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Omnicare Tops Est., Higher Profit - Analyst Blog</title>
      <description>Provider of drugs to long-term care facilities and nursing homes,  Omnicare Inc.  (  OCR  ) posted fourth-quarter 2012 adjusted (excluding one-time expenses) earnings per share of 86 cents&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/wtZKdIomluA" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 20 Feb 2013 18:30:01 Z</pubDate>
      <a10:updated>2013-02-20T14:52:00Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AIRM</nasdaq:tickers>
      <nasdaq:tickers>CVD</nasdaq:tickers>
      <nasdaq:tickers>OCR</nasdaq:tickers>
      <nasdaq:tickers>PMC</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/omnicare-tops-est-higher-profit-analyst-blog-cm219231</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/esrx-reports-inline-4q-earnings-analyst-blog-cm218999">
      <guid isPermaLink="false">218999</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RotjwTUMYic/esrx-reports-inline-4q-earnings-analyst-blog-cm218999</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>ESRX Reports In-Line 4Q Earnings  - Analyst Blog</title>
      <description>Express Scripts Holding Company's  (  ESRX  ) fourth quarter 2012 adjusted earnings of $1.05 per share were in-line with the Zacks Consensus Estimate, and increased 28.1% from the year-ago&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/RotjwTUMYic" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 20 Feb 2013 00:58:01 Z</pubDate>
      <a10:updated>2013-02-19T21:52:19Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CVD</nasdaq:tickers>
      <nasdaq:tickers>ESRX</nasdaq:tickers>
      <nasdaq:tickers>OCR</nasdaq:tickers>
      <nasdaq:tickers>PRXL</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/esrx-reports-inline-4q-earnings-analyst-blog-cm218999</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/premarket-earnings-report-for-february-19-2013-mdt-gpc-ni-wlk-xec-win-yndx-wab-roc-ocr-see-awi-cm218360">
      <guid isPermaLink="false">218360</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7p4evfEg3Co/premarket-earnings-report-for-february-19-2013-mdt-gpc-ni-wlk-xec-win-yndx-wab-roc-ocr-see-awi-cm218360</link>
      <category>News Headlines</category>
      <category>Earnings</category>
      <title>Pre-Market Earnings Report for February 19, 2013 :  MDT, GPC, NI, WLK, XEC, WIN, YNDX, WAB, ROC, OCR, SEE, AWI</title>
      <description>The following companies are expected to report earnings prior to market open on 02/19/2013. Visit our  Earnings Calendar  for a full list of expected earnings releases.   Medtronic, Inc.  (  MDT&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/7p4evfEg3Co" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 16 Feb 2013 02:00:04 Z</pubDate>
      <a10:updated>2013-02-15T21:15:07Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>AWI</nasdaq:tickers>
      <nasdaq:tickers>GPC</nasdaq:tickers>
      <nasdaq:tickers>MDT</nasdaq:tickers>
      <nasdaq:tickers>NI</nasdaq:tickers>
      <nasdaq:tickers>OCR</nasdaq:tickers>
      <nasdaq:tickers>ROC</nasdaq:tickers>
      <nasdaq:tickers>SEE</nasdaq:tickers>
      <nasdaq:tickers>WAB</nasdaq:tickers>
      <nasdaq:tickers>WIN</nasdaq:tickers>
      <nasdaq:tickers>WLK</nasdaq:tickers>
      <nasdaq:tickers>XEC</nasdaq:tickers>
      <nasdaq:tickers>YNDX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/premarket-earnings-report-for-february-19-2013-mdt-gpc-ni-wlk-xec-win-yndx-wab-roc-ocr-see-awi-cm218360</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/mixed-4q-for-charles-river-analyst-blog-cm217896">
      <guid isPermaLink="false">217896</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_cwoLo9svs4/mixed-4q-for-charles-river-analyst-blog-cm217896</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Mixed 4Q for Charles River - Analyst Blog</title>
      <description>Charles River Laboratories  (  CRL  ) reported fourth quarter 2012 earnings (excluding special items) of 64 cents per share, beating the Zacks Consensus Estimate of 60 cents. Earnings declined&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/_cwoLo9svs4" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 15 Feb 2013 01:27:01 Z</pubDate>
      <a10:updated>2013-02-14T21:52:52Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CRL</nasdaq:tickers>
      <nasdaq:tickers>CVD</nasdaq:tickers>
      <nasdaq:tickers>EMD</nasdaq:tickers>
      <nasdaq:tickers>OCR</nasdaq:tickers>
      <nasdaq:tickers>PCS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mixed-4q-for-charles-river-analyst-blog-cm217896</feedburner:origLink></item>
  </channel>
</rss>
